the offer is not sufficient financially to ensure a business. , Monsanto announced in St. Louis on Tuesday. But Monsanto remains open to discussions with the Leverkusen-based company and other parties, it said. Bayer informed on request only with: “We consider the answer.”
The market was so cold: Bayer shares forfeited to the DAX around one percent of its value. Monsanto shares were registered in the US also under some pressure.
WORKS NEEDED INDOOR DECISION ON
Bayer had raised slightly its offer last week from 122 to 125 US dollars per share , Overall, this means an extra cost of around 1.3 billion US dollars. On the market, it is assumed that the Germans wanted the Americans to move in this way to provide insight into the books. This would facilitate Bayer, to get an accurate picture of the value of the US company. Analysts expect that the doors could probably open from around 130 dollars.
The head of the Central Bayer, Oliver Zühlke, warned meanwhile a speedy decision on. “The faster the takeover battle is decided, the better. Each new message take the speculation in the Group “, Zühlke told the” Rheinische Post “(Wednesday edition). A further increase of the offer is for the Executive Board. This knew what he could expect the Group financially. “Strategically, the acquisition makes sense”, Zühlke.
BAYER PROMOTES THE OFFER
Bayers originating offer said totaled $ 62 billion, including the debt of Monsanto. Bayer offered Monsanto last beyond a so-called break fee of $ 1.5 billion in case the antitrust approvals should not be granted. The increase recorded Bayer made possible after the company had received in confidential discussions with Monsanto additional information, it was then called. Bayer spoke of a “highly attractive” offer for Monsanto shareholders. They offer the best opportunity for immediate and safe appreciation for their shares, said Bayer CEO Werner Baumann last Thursday. Bayer have the firm intention to complete this transaction.
The Leverkusen had surprisingly announced the proposed acquisition of seed specialists from the United States in May. The German company would rise through the record-merger the world’s number one in the agricultural chemicals business. Nevertheless, the deal was controversial from the start. Monsanto is in Europe for years because of its genetically modified products in the review
CRITICISM OF MONSANTO
The US manufacturers of genetically modified seeds is under accused others ruppiges behavior in dealing with its customers. In addition, Monsanto sells the weedkiller glyphosate. This is suspected to be carcinogenic. Monsanto marketed glyphosate under the name Roundup. Recently, the EU Commission had extended the European approval of the controversial weed shredder by up to 18 months.
Monsanto According circles recently talking with the Bayer competitors BASF through a combination of the respective agrochemical divisions resumed. The Americans tested various transactions including the acquisition of BASF’s business with solutions for the agricultural economy, the news agency Bloomberg had about a week ago, citing reports with the matter people.
A LOT OF MOVEMENT IN THE INDUSTRY
in the industry generally much in motion: How will the Swiss agricultural chemicals supplier Syngenta swallow for about $ 43 billion of Chinese chemical company ChemChina. The US rival Dow Chemical and Dupont want to go together. They would thus once the industry leader BASF dethrone. However, the two US corporations want to split following the proposed merger in three listed companies.
No comments:
Post a Comment